Otorhinolaryngological Problems in Mucopolysaccharidoses: A Review of Common Symptoms in a Rare Disease

Overview

Journal Brain Sci

Publisher MDPI

Date 2024 Nov 27

PMID 39595849

Authors

Anna Wasniewska-Wlodarczyk

Renata Pepas

Oskar Rosiak

Wieslaw Konopka

Affiliations

Soon will be listed here.

Abstract

Background: The mucopolysaccharidoses (MPSs) are very rare lysosomal diseases. MPSs belong to inherited diseases; however, newborns are usually asymptomatic. A deficiency of one of the enzymes, which is responsible for glycosaminoglycan (GAG) catabolism, results in the accumulation of this material. GAGs lead to progressive damage to tissues. More than 90% of patients with MPS suffer from otitis media with effusion or recurrent otitis media, craniofacial dysmorphia, obstructive sleep apnea, different types of hearing loss, and progressive upper and lower airway dysfunction. Patients visit otolaryngologists often before the diagnosis of MPS. Thus, the awareness of symptoms of MPS is crucial for otolaryngologists and pediatricians. The earlier the diagnosis is made, the more effective treatment is. Ineffective or delayed treatment leads to premature death. Two principal treatments for MPS are currently available: hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT). In recent years, there has been a growing interest in gene therapy as a potential treatment for patients with MPS. Mortality in patients with MPS typically occurs during childhood and early adolescence as a consequence of upper and lower respiratory diseases.

Methods: This systematic review is based on papers available in the following scientific databases: MEDLINE (via PubMed), Web of Science, Scopus, and the Cochrane Library.

Results: After screening, 72 articles met our inclusion criteria.

Conclusions: It is of paramount importance that otolaryngologists are involved in this field. This narrative review examines and synthesizes the otolaryngologic issues encountered in patients with MPS.

References

Santamaria F, Andreucci M, Parenti G, Polverino M, Viggiano D, Montella S . Upper airway obstructive disease in mucopolysaccharidoses: polysomnography, computed tomography and nasal endoscopy findings. J Inherit Metab Dis. 2007; 30(5):743-9. DOI: 10.1007/s10545-007-0555-5. View

Zhou J, Lin J, Leung W, Wang L . A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management. Intractable Rare Dis Res. 2020; 9(1):1-9. PMC: 7062595. DOI: 10.5582/irdr.2020.01011. View

Pal A, Mercer J, Jones S, Bruce I, Bigger B . Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy. PLoS One. 2018; 13(9):e0203216. PMC: 6143186. DOI: 10.1371/journal.pone.0203216. View

Yeung A, Cowan M, Horn B, Rosbe K . Airway management in children with mucopolysaccharidoses. Arch Otolaryngol Head Neck Surg. 2009; 135(1):73-9. DOI: 10.1001/archoto.2008.515. View

Yigit O, Aksoy S, Akyol U, Tokatli A, Sivri H . Sensory, voluntary, and motor postural control in children and adolescents with mucopolysaccharidosis. J Pediatr Endocrinol Metab. 2021; 34(5):583-589. DOI: 10.1515/jpem-2020-0630. View

Sofronova V, Gotovtseva L, Danilova A, Sukhomyasova A, Moriwaki T, Terawaki S . Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS). Genes (Basel). 2023; 14(8). PMC: 10454871. DOI: 10.3390/genes14081581. View

Mierzwinski J, Zwierz A, Jaworski A, Redzinski R, Bandrowicz W, Dalke K . [The use of Nd-Yag laser in the treatment of tracheal tumor in 14 years old child with mukopolisacharydosis type II]. Otolaryngol Pol. 2006; 60(4):603-6. View

Ruttkay Pereira D, Schweiger C, De Souza C, Fagondes S, Manica D, Giugliani R . Correlation Between Flexible Fiberoptic Laryngoscopic and Polysomnographic Findings in Patients with Mucopolysaccharidosis Type VI. JIMD Rep. 2015; 29:53-58. PMC: 5059190. DOI: 10.1007/8904_2015_513. View

Elwell Z, Mancuso D, Wolter N, Propst E, Valdez T, Scheffler P . Post-tonsillectomy outcomes in children with mucopolysaccharidosis and obstructive sleep apnea. J Otolaryngol Head Neck Surg. 2023; 52(1):87. DOI: 10.1186/s40463-023-00685-y. View

10.

Zerjav Tansek M, Kodric J, Klemencic S, Boelens J, van Hasselt P, Drole Torkar A . Therapy-type related long-term outcomes in mucopolysaccaridosis type II (Hunter syndrome) - Case series. Mol Genet Metab Rep. 2021; 28:100779. PMC: 8251508. DOI: 10.1016/j.ymgmr.2021.100779. View

11.

Wolfberg J, Chintalapati K, Tomatsu S, Nagao K . Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions. Diagnostics (Basel). 2020; 10(8). PMC: 7460463. DOI: 10.3390/diagnostics10080554. View

12.

Sarmento D, Carvalho S, Sousa Melo S, Alves Fonseca F, Diniz D, Bento P . Mucopolysaccharidosis: radiographic findings in a series of 16 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120(6):e240-6. DOI: 10.1016/j.oooo.2015.08.009. View

13.

Cohen M, Stuart G . Delivery of anesthesia for children with Mucopolysaccharidosis Type III (Sanfilippo syndrome): a review of 86 anesthetics. Paediatr Anaesth. 2017; 27(4):363-369. DOI: 10.1111/pan.13075. View

14.

Morehead J, PARSONS D . Tracheobronchomalacia in Hunter's syndrome. Int J Pediatr Otorhinolaryngol. 1993; 26(3):255-61. DOI: 10.1016/0165-5876(93)90096-l. View

15.

Pires de Mello P, Barth A, Torres D, Pires de Mello Valente M, Horovitz D . Laryngeal, Tracheal, and Bronchial Disease in the Mucopolysaccharidoses: Endoscopic Study. Diagnostics (Basel). 2020; 10(1). PMC: 7169448. DOI: 10.3390/diagnostics10010037. View

16.

Facchina G, Amaddeo A, Baujat G, Breton S, Michot C, Thierry B . A retrospective study on sleep-disordered breathing in Morquio-A syndrome. Am J Med Genet A. 2018; 176(12):2595-2603. DOI: 10.1002/ajmg.a.40642. View

17.

van den Broek B, Smit A, Boelens J, van Hasselt P . Hearing loss in patients with mucopolysaccharidoses-1 and -6 after hematopoietic cell transplantation: A longitudinal analysis. J Inherit Metab Dis. 2020; 43(6):1279-1287. PMC: 7689745. DOI: 10.1002/jimd.12277. View

18.

Leighton S, Papsin B, Vellodi A, Dinwiddie R, Lane R . Disordered breathing during sleep in patients with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol. 2001; 58(2):127-38. DOI: 10.1016/s0165-5876(01)00417-7. View

19.

Keilmann A, Lassig A, Pollak-Hainz A, Mann W, Beck M, Hainz M . Adenoids of patients with mucopolysaccharidoses demonstrate typical alterations. Int J Pediatr Otorhinolaryngol. 2014; 79(2):115-8. DOI: 10.1016/j.ijporl.2014.11.014. View

20.

Arn P, Bruce I, Wraith J, Travers H, Fallet S . Airway-related symptoms and surgeries in patients with mucopolysaccharidosis I. Ann Otol Rhinol Laryngol. 2014; 124(3):198-205. PMC: 4361463. DOI: 10.1177/0003489414550154. View